Eclat Pharmaceuticals, L.L.C.

eclatpharma.com

Éclat Pharmaceuticals, L.L.C., a St. Louis, Missouri- based specialty pharmaceutical company is focused on the development, approval and commercialization of niche brand and generic products. Eclat’s mission is simple: Improve today’s medicine for better patient outcomes tomorrow.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

NEURIMMUNE EXPANDS DRUG DISCOVERY COLLABORATION WITH ONO PHARMACEUTICAL IN THE FIELD OF NEURODEGENERATIVE DISEASES

Neurimmune | January 17, 2022

news image

Neurimmune AG today announced that it has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. The collaboration is focused on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases utilizing Neurimmune's proprietary Reverse Translational Medicine™ technology platform, a unique antibody drug creation approach. In November 2017, Ono and Neurimmune signed a first drug discovery collabo...

Read More

LILLY LAUNCHES DIGITAL HEALTH OPEN INNOVATION CHALLENGE TO HELP TRANSFORM ATOPIC DERMATITIS CARE

Eli Lilly and Company | September 16, 2020

news image

Eli Lilly and Company has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Dermatitis Care: Enhancing Quality of Life and Patient Care for People Living with Inflammatory Skin Diseases," focuses on leveraging digital technologies to enhance care and improve health and well-being for people with ...

Read More

Pharma Tech

AERORX PARTNERS WITH HCMED TO DEVELOP A NEBULIZED LABA/LAMA COMBINATION SOLUTION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

AeroRx Partners | October 03, 2022

news image

AeroRx Therapeutics, LLC. and HCmed Innovations Co., Ltd. have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer. This collaboration sets forth the framework by which both companies will work together to develop a new nebulized combination formulation for the treatment of chronic obstructive pulmonary disease. According to market reports, it is estimated that there would be close to 34.5 million COPD patients worl...

Read More

SALESFORCE LAUNCHES NEW HYBRID CMS PLATFORM 'SALESFORCE CMS’

DECK 7 | February 04, 2020

news image

Demand owns content, and with the release of 'Salesforce CMS', it’s clear that Salesforce is putting the control squarely with demand, not to mention delighting the creative marketer with more power through additional tools for creating content that are expected to work well right out of the box (er… cloud). Customers have become accustomed to consuming content across multiple channels and platforms which requires marketers to provide for seamless integration of their conten...

Read More
news image

Business Insights

NEURIMMUNE EXPANDS DRUG DISCOVERY COLLABORATION WITH ONO PHARMACEUTICAL IN THE FIELD OF NEURODEGENERATIVE DISEASES

Neurimmune | January 17, 2022

Neurimmune AG today announced that it has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. The collaboration is focused on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases utilizing Neurimmune's proprietary Reverse Translational Medicine™ technology platform, a unique antibody drug creation approach. In November 2017, Ono and Neurimmune signed a first drug discovery collabo...

Read More
news image

LILLY LAUNCHES DIGITAL HEALTH OPEN INNOVATION CHALLENGE TO HELP TRANSFORM ATOPIC DERMATITIS CARE

Eli Lilly and Company | September 16, 2020

Eli Lilly and Company has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Dermatitis Care: Enhancing Quality of Life and Patient Care for People Living with Inflammatory Skin Diseases," focuses on leveraging digital technologies to enhance care and improve health and well-being for people with ...

Read More
news image

Pharma Tech

AERORX PARTNERS WITH HCMED TO DEVELOP A NEBULIZED LABA/LAMA COMBINATION SOLUTION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

AeroRx Partners | October 03, 2022

AeroRx Therapeutics, LLC. and HCmed Innovations Co., Ltd. have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer. This collaboration sets forth the framework by which both companies will work together to develop a new nebulized combination formulation for the treatment of chronic obstructive pulmonary disease. According to market reports, it is estimated that there would be close to 34.5 million COPD patients worl...

Read More
news image

SALESFORCE LAUNCHES NEW HYBRID CMS PLATFORM 'SALESFORCE CMS’

DECK 7 | February 04, 2020

Demand owns content, and with the release of 'Salesforce CMS', it’s clear that Salesforce is putting the control squarely with demand, not to mention delighting the creative marketer with more power through additional tools for creating content that are expected to work well right out of the box (er… cloud). Customers have become accustomed to consuming content across multiple channels and platforms which requires marketers to provide for seamless integration of their conten...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us